Solnerstotug (SNS-101) dose expansion arm anticipated to be fully enrolled by end of Q1 2025 -- Clinical data update expected in Q2 2025 - ...

The patent, when formally approved, will reinforce protection for Silo’s lead asset, SPC-15, an intranasal treatment targeting post-traumatic stress disorder (PTSD). The patent includes newly added ...

The biotech group struggled as a whole in 2024, but analysts say the innovation that has always supported the biotech ...

Tesla stock slipped on Tuesday after Bank of America said it sees shares fairly priced, with some risk to the downside. As Nvidia races to bring more of its next-gen chips online, CEO Jensen Huang ...

Catalyst (CPRX) stock jumped 15% on news the company had reached an agreement with Teva (TEVA) that would delay the launch of ...

Jasper Therapeutics' SPOTLIGHT study reports 93% clinical response in cold urticaria and symptomatic dermographism. The 120mg dose showed 83% complete response and no severe adverse events.

Why Keysight Technologies Shares Are Trading Higher By Over 9%; Here Are 20 Stocks Moving Premarket ...

Japan Airlines Co. Ltd.-1.07% ¥1.08T ...